跳至主要内容
临床试验/NCT00357942
NCT00357942已完成4 期

Local Administration of Morphine: An Evaluation of the Analgesic Effect at Stomatitis in Children

Danish University of Pharmaceutical Sciences1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2006年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
72
试验地点
1
主要终点
Use of supplemental analgesics

研究概览

简要总结

Stomatitis/oral mucositis is a common side effect to chemotherapy. Stomatitis is often associated with painful ulcers in the mouth. The study hypothesis is that morphine administrated as a mouthwash can relieve stomatitis-related pain by a local analgesic effect.

The purpose of this study is to test the analgesic effect of a morphine mouthwash versus morphine injections or placebo (no active drug) in children/adolescents with stomatitis related to chemotherapy. Besides the investigational drugs (morphine mouthwash and morphine injections) the children/adolescents receive a standardized analgesic treatment for stomatitis-related pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Children and adolescents at The Juliane Marie Center at Copenhagen University Hospital (Rigshospitalet, Denmark) or at The University Hospital in Lund (Sweden)
  • Receiving chemotherapy in relation to a cancer disease
  • Pain score of minimum 3 (VAS-scale) at rest for mouth pain in combination with stomatitis of minimum grade 1 (WHO-scale) or a pain score of minimum 5 (VAS-scale) at activity for mouth pain in combination with stomatitis of minimum grade 1 (WHO-scale)
  • Negative pregnancy test, when relevant (judged by physician)
  • Patients and/or parents understand and speak danish (Denmark) / swedish (Sweden)
  • Signed informed consent

排除标准

  • Allergic to the investigational medical product
  • Alcohol or drug abuse

研究组 & 干预措施

C group I

Experimental

Morphine mouthwash and placebo i.v.(24 hours) Added on standard analgesic treatment (paracetamol and patient controlled analgesia, morphine)

干预措施: morphine mouthwash (Drug)

C group II

Active Comparator

Placebo mouthwash and morphine i.v.(24 hours) Added on standard analgesic treatment (paracetamol and patient controlled analgesia, morphine)

干预措施: Placebo (Drug)

C group I

Experimental

Morphine mouthwash and placebo i.v.(24 hours) Added on standard analgesic treatment (paracetamol and patient controlled analgesia, morphine)

干预措施: Placebo (Drug)

C group II

Active Comparator

Placebo mouthwash and morphine i.v.(24 hours) Added on standard analgesic treatment (paracetamol and patient controlled analgesia, morphine)

干预措施: morphine solution for injection (Drug)

C group III

Placebo Comparator

Placebo mouthwash and placebo i.v. (24 hours) Added on standard analgesic treatment (paracetamol and patient controlled analgesia, morphine)

干预措施: Placebo (Drug)

结局指标

主要结局

Use of supplemental analgesics

时间窗: 24 hours

次要结局

  • Pain score at rest(24 hours)
  • Pain score at activity (performance of oral hygiene)(24 hours)
  • Time to first dose of supplemental analgesics(24 hours)
  • Frequency and severity of side effects(24 hours)
  • Oral intake of food(24 hours)

研究者

发起方
Danish University of Pharmaceutical Sciences
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bettina Nygaard Nielsen

M.Sc. Pharm, sponsor contact person

Danish University of Pharmaceutical Sciences

研究点 (1)

Loading locations...

相似试验